Search Within

Genitourinary Oncology Service

  1. "James Harding"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (17)
Groups
  1. Department of Medicine (50)
  2. Gastrointestinal Oncology Service (50)
  3. Solid Tumor Oncology Division (50)
  4. GSK Faculty (35)
  5. Human Oncology and Pathogenesis Program (34)
  6. Department of Pathology and Laboratory Medicine (33)

More Groups

People
  1. James Harding (50)
  2. David Solit (33)
  3. Michael Berger (28)
  4. Ghassan Abou-Alfa (25)
  5. Eileen O'Reilly (17)
  6. Nikolaus Schultz (15)

More People

Years
  1. 2025 (5)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (7)
  3. JCO Precision Oncology (6)
  4. Annals of Oncology (3)
  5. Investigational New Drugs (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (8)
  3. Oxford University Press (5)
  4. Nature Publishing Group (4)
  5. American Medical Association (2)
  6. Elsevier Inc. (2)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical utility and prognostic implications of circulating cell-free DNA in biliary tract cancer
    Journal Article

    Cowzer, D.; Darmofal, M.; Seier, K.; Thummalapalli, R.; Walch, H.; El Dika, I.; Khalil, D. N.; Park, W.; Dhyani, A.; Yaqubie, A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Automated portal-enabled elicitation of health-related patient values in solid tumor oncology: Feasibility and patient characteristics associated with patient response
    Journal Article

    Epstein, A. S.; Knezevic, A.; Hoque, A.; Rosa, W. E.; Harding, J. J.; Raj, N.; Reidy, D.; Iyer, G. V.; Applebaum, A. J.; Nelson, J. E.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Neratinib alone or in combination with immune checkpoint inhibitors with or without mammalian target of rapamycin inhibitors in patients with fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Meyer, T.; Do, R. K. G.; Piha-Paul, S. A.; Light, J. S.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Harding, J. J.; Al-Rajabi, R.; more...
    Liver Cancer (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
    Journal Article

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Murphy, J. J.; Cleary, J. M.; Shapiro, G. I.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save